Benchmarking Synthetic Data Solutions: A Technical Comparison
The demand for privacy-preserving, scalable data has pushed synthetic data solutions to the forefront of AI development. Data engineers must juggle…
Read more →Tempus operates CLIA-certified genomic sequencing labs and has built a library of more than 8.5 million de-identified patient records, including over 1.5 million linking clinical and genomic data, which it licenses alongside its diagnostics to life-sciences and provider partners. Tempus is publicly traded (Nasdaq: TEM).
Multimodal